© 2022 MJH Life Sciences and Center for Biosimilars®. All rights reserved.
© 2022 MJH Life Sciences™ and Center for Biosimilars®. All rights reserved.
December 16, 2016
Payers will have to carefully mull limited options.
Value-based health care has forced several systemic changes.
December 15, 2016
Sometimes the actual study results are less the point than the objectives of the investigators.
December 14, 2016
Enthusiasm dulled for new US biosimilar Inflectra for Rheumatoid Arthritis.
December 13, 2016
New study in a small sample of physicians implies cost factor could be a big influence.
Gaining rapid uptake for biosimilar products is a challenge for manufacturers and payers.